The investment will support the commercial development and market launch of StrokePointer™
The StrokePointer™ of TrianecT is a solution with which stroke can be diagnosed in the ambulance by the acquisition of electrical brain activity of the patient and its automatic analysis. The goal of StrokePointer™ is to enable triage of stroke patients in the ambulance, providing emergency medical service (EMS) personnel with the opportunity to transport patients directly to the right hospital for the right treatment.
Congrats Wouter Potters and team!